Commercial Determinants of Health: Implications for Health Interventions
Professor Emma Boyland explores how the food industry’s marketing, lobbying, and science manipulation drive poor diet and obesity, and outlines the mandatory, system-wide policies needed to protect public health. Drawing on global examples, she highlights practical strategies to counter commercially driven health harms.
- Pre Questionnaire
- Video
- Post Questionnaire
- Prof. Emma Boyland
- Drivers of Obesity
Hi, I'm Professor Emma Boyland, a psychologist who researches eating behaviour and food policy based in the UK.
In the next five minutes, I'm going to provide some important insights into commercially driven health harms and the ways in which public health interventions and strategies can mitigate these harms.
Let's get started.
Poor diet and obesity play an important role in people experiencing poor health and early death.
The food industry's products are highly processed, affordable, available, and when we consume them, they're damaging our health.
The commercial determinants of health are the systems, practices, and pathways through which commercial actors affect health and equity.
Today I'm focusing on food, but there are parallels with alcohol, fossil fuels, tobacco industries.
Let's think about some of the ways in which the actions of the food industry directly and indirectly affect our health.
First, they aggressively advertise their products and brands in all sorts of media and settings, with the biggest growth being online.
There is strong research evidence that this makes us buy and eat more unhealthy advertised foods.
Second, they lobby policymakers to weaken, delay or scrap public health policies and use media as a vehicle to deploy arguments against such policies.
Third, they actively seek to undermine the science that is underpinning the regulatory actions they are afraid of.
They also try to create the illusion of support that a lot of people and studies agree with their stance.
So what are the implications of this for public health interventions and strategies?
First, public health policy interventions must be mandatory, not voluntary.
Industries cannot simultaneously profit from a problem and solve it.
Evidence shows mandatory policies are more effective.
Second, approaches must be comprehensive in scope, addressing multiple areas of the food system.
Think of the squeezed balloon.
Pressure applied in one place gets released elsewhere.
Third, synergy across the system is important.
If the definitions and processes underpinning the strategy are consistent across, for example, food labelling, food marketing, point of sale regulations and so on, then the development and implementation is much more efficient.
Chile is a great example of this.
Fourth, the aim should be for incremental integrated progress towards the public health goal.
No single policy can tackle these public health challenges.
We can't afford to wait for the perfect solution.
We need to start somewhere and add and develop.
I'm Professor Emma Boylan for 5 Minute CPD.
Thanks for watching and be sure to check out additional resources on this page and more learning at eso.org.
- Conceptualizing the commercial determinants of dietary behaviors associated with obesity: A systematic review using principles from critical interpretative synthesis – Chavez‐Ugalde – 2021 – Obesity Science & Practice – Wiley Online Library
- Defining and conceptualising the commercial determinants of health – The Lancet
- Association of Food and Nonalcoholic Beverage Marketing With Children and Adolescents’ Eating Behaviors and Health: A Systematic Review and Meta-analysis | Lifestyle Behaviors | JAMA Pediatrics | JAMA Network
- Systematic review of the effect of policies to restrict the marketing of foods and non‐alcoholic beverages to which children are exposed – Boyland – 2022 – Obesity Reviews – Wiley Online Library
- Corporate Lobbying: The Dark Side of the Plate | Food Foundation
- Policies to protect children from the harmful impact of food marketing: WHO guideline
View all CPD
EASO has received funding to support components of the 5-MIN CPD programme via an unrestricted grant from Boehringer-Ingelheim. Boehringer-Ingelheim had no influence over the content of any of the modules.